EndoBridge 2023: highlights and pearls-Reference-Cited by-同舟云学术

EndoBridge 2023: highlights and pearls

Published:2024-04-15 Issue:2 Volume:23 Page:183-204
ISSN:1109-3099
Container-title:Hormones
language:en
Short-container-title:Hormones

Author:

Yildiz Bulent Okan^ORCID,Boguszewski Cesar Luiz,da Silva Boguszewski Margaret Cristina,Busetto Luca,Celik Ozlem,Fuleihan Ghada El-Hajj,Goulis Dimitrios G.,Hammer Gary D.,Haymart Megan R.,Kaltsas Gregory,Law Jennifer R.,Lim Amanda Yuan Ling,Luger Anton,Macut Djuro,McGowan Barbara,McClung Michael,Miras Alexander Dimitri,Patti Mary Elizabeth,Peeters Robin P.,Pignatelli Duarte,Saeed Hamayle,Sipos Jennifer,Stratakis Constantine A.,Tsoli Marina,van der Lely A. J.,Witchel Selma F.,Yazici Dilek

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s42000-024-00549-8.pdf

Reference77 articles.

1. Samson SL, Nachtigall LB, Fleseriu M et al (2020) Maintenance of acromegaly control in patients switching from injectable somatostatin receptor ligands to oral octreotide. J Clin Endocrinol Metab 105:e3785–e3797. https://doi.org/10.1210/clinem/dgaa526

2. Melmed S, Popovic V, Bidlingmaier M et al (2015) Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial. J Clin Endocrinol Metab 100:1699–1708. https://doi.org/10.1210/jc.2014-4113

3. Madan A, Zhu YF, Markison S et al (2019) Final results from the first in man phase 1 clinical trial of CRN00808, an orally bioavailable sst2-selective, nonpeptide somatostatin biased agonist, for the treatment of acromegaly: safety, pharmacokinetics, pharmacodynamics, and midazolam drug interaction in healthy volunteers. J Endocr Soc 3(Suppl-1):SAT–249

4. Basu R, Nahar K, Kulkarni P et al (2021) A novel peptide antagonist of the human growth hormone receptor. J Biol Chem 296:100588. https://doi.org/10.1016/j.jbc.2021.100588

5. Brito JP, Ross JS, El Kawkgi OM, Maraka S, Deng Y, Shah ND, Lipska KJ (2021) Levothyroxine use in the United States, 2008–2018. JAMA Intern Med 181:1402–1405. https://doi.org/10.1001/jamainternmed.2021.2686

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apropos thyroid endocrinology and EndoBridge, as well as more on reproductive medicine;Hormones;2024-06